Furthermore, as IL-1 β is a major contributor to both chronic liver and atherosclerotic CVD [33,34,35,36], the fact that AAA-1 PI increases IL-1 β transcription further supports the hypothesis that these autoantibodies could facilitate MASH development as well. The gene discussed is NPSR1-AS1; the disease is medical procedure.